Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |